Pharmxon

 (Ceftrixone Sodium USP)

250 mg, 500 mg,1 gm,2 gm

The Power To Cover Most Of The Commonly Found Bacterial Organisms In Life Threatening Infections

THREATS TYPHOID FEVER EEFECTIVELY

PHARMXON is effective against both non-MDR and MDR Salmonella Typhi Strains Becausa.

PHARMXON offers high tissue and fluid concentration with convinient OD dosage.

Ref:PDR,58th edition,2004p2938

MENINGITIS

The new guidelines recommend a third generation cephalosporin such as ... Ceftriaxone PHARMXON as the first line of treatment In most patients ...

Ref: BMJ 2003;326:996-997 (I O may).

RESPIRATORY TRACT INFECTIONS

Cefriaxone PHARMXON preferred agent for pneumococcal pneumonia involving the 95% of strains with an MIC of <2jL/g/ml.

Ref: clinical Infectious Disease 2003;37:1405-1433

URINARY TRACT INFECTIONS

Infants from 28 days to 3 months of age who are not acutely ill with a febrile UT1 maybe managed as outpatients. Ceftriaxone PHARMXON should be administered parenterally

Ref: Minerva Pedlatr  2003 Oct; 55 (5); 395-406t

SEPTICAEMIA

Ceftriaxone PHARMXON is the drug of  choice for the treatment of Septicaemia.

Ref: Good man & Gillman’s.The pharma-cological basis of  Therapeutics, 9th edition.

PHARMXON OFFERS UNMATCHED BENEFITS LIKE

PHARMXON provides excellent pharmacokinetics profile.

PHARMXON is safe and effective especially in children.

PHARMXON cover both MDR & non-MDR salmonella typha strains.

PHARMXON offers high concentration in bile & faeces.

PHARMXON shows convenience with OD dosage.

PHARMXON is safe and well tolerated in renal compromised patients.